Association of cholesterol oxidation and abnormalities in fatty acid metabolism in cystic fibrosis

American Journal of Clinical Nutrition

Volumn 90, Issue 3, 2009, Pages 477-484

  Iuliano, Luigi ^a   Monticolo, Roberto ^a   Straface, Giuseppe ^a   Zullo, Sabina ^a   Galli, Francesco ^b   Boaz, Mona ^c   Quattrucci, Serena ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

7 OXOCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; CHOLESTEROL; FATTY ACID; MONOUNSATURATED FATTY ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OLEIC ACID; OMEGA 6 FATTY ACID; OXYSTEROL; POLYUNSATURATED FATTY ACID; STEROID; 7-KETOCHOLESTEROL; BIOLOGICAL MARKER; CHOLEST 5 EN 3 BETA,7 ALPHA DIOL; CHOLEST-5-EN-3 BETA,7 ALPHA-DIOL; CHOLESTEROL DERIVATIVE;

ADULT; ARTICLE; BLOOD ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FATTY ACID METABOLISM; FEMALE; HUMAN; LIPID ANALYSIS; LIPID METABOLISM; LIPID OXIDATION; LIVER DISEASE; MALE; MASS SPECTROMETRY; OXIDATIVE STRESS; PANCREAS INSUFFICIENCY; VITAMIN SUPPLEMENTATION; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; METABOLISM; NONPARAMETRIC TEST; OXIDATION REDUCTION REACTION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHOLESTEROL; CYSTIC FIBROSIS; FATTY ACIDS; FEMALE; HUMANS; HYDROXYCHOLESTEROLS; KETOCHOLESTEROLS; MALE; MASS SPECTROMETRY; OXIDATION-REDUCTION; OXIDATIVE STRESS; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 70349570175     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.27757     Document Type: Article

References (39)

1. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073 (Pubitemid 19231814)
2. Roulet M, Frascarolo P, Rappaz I, Pilet M. Essential fatty acid deficiency in well nourished young cystic fibrosis patients. Eur J Pediatr 1997;156:952-956 (Pubitemid 28006316)
3. Wood LG, Fitzgerald DA, Garg ML. Hypothesis: vitamin E complements polyunsaturated fatty acids in essential fatty acid deficiency in cystic fibrosis. J Am Coll Nutr 2003;22:253-257 (Pubitemid 36927759)
4. Andersson C, Al-Turkmani MR, Savaille JE, et al. Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism. J Lipid Res 2008;49:1692-1700
5. Freedman SD, Blanco PG, Zaman MM, et al. Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 2004;350:560-569
6. Brown RK, Kelly FJ. Role of free radicals in the pathogenesis of cystic fibrosis. Thorax 1994;49:738-742 (Pubitemid 24250228)
7. Lucidi V, Ciabattoni G, Bella S, Barnes PJ, Montuschi P. Exhaled 8-isoprostane and prostaglandin E(2) in patients with stable and unstable cystic fibrosis. Free Radic Biol Med 2008;45:913-919
8. Ciabattoni G, Davi G, Collura M, et al. In vivo lipid peroxidation and platelet activation in cystic fibrosis. Am J Respir Crit Care Med 2000;162:1195-1201
9. Lemaire-Ewing S, Prunet C, Montange T, et al. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol Toxicol 2005;21:97-114. (Pubitemid 41253203)
10. Micheletta F, Iuliano L. Free radical attack on cholesterol: oxysterols as markers of oxidative stress and as bioactive molecules. Immun Endoc Metab Agents in Med Chem 2006;6:305-316 (Pubitemid 44082861)
11. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998;132:589-595
12. Colombo C, Battezzati PM, Crosignani A, et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology 2002;36:1374-1382 (Pubitemid 35403528)
13. Kerem E, Conway S, Elborn S, Heijerman H. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005;4:7-26. (Pubitemid 40347773)
14. Taussig LM, Kattwinkel J, Friedewald WT, Di Sant'Agnese PA. A new prognostic score and clinical evaluation system for cystic fibrosis. J Pediatr 1973;82:380-390
15. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002;35:246-259
16. Iuliano L, Micheletta F, Natoli S, et al. Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. Anal Biochem 2003;312:217-223 (Pubitemid 36151134)
17. Liebler DC, Burr JA, Philips L, Ham AJ. Gas chromatography-mass spectrometry analysis of vitamin E and its oxidation products. Anal Biochem 1996;236:27-34. (Pubitemid 26103104)
18. Larsson H, Bottiger Y, Iuliano L, Diczfalusy U. In vivo interconversion of 7beta-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress. Free Radic Biol Med 2007;43:695-701.
19. Traber MG, Jialal I. Measurement of lipid-soluble vitamins - further adjustment needed? Lancet 2000;355:2013-2014
20. Masood A, Stark KD, Salem N Jr. A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies. J Lipid Res 2005;46:2299-2305 (Pubitemid 41377483)
21. Zieden B, Kaminskas A, Kristenson M, et al. Increased plasma 7 beta-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease. Arterioscler Thromb Vasc Biol 1999;19:967-971 (Pubitemid 29177344)
22. Alkazemi D, Egeland G, Vaya J, Meltzer S, Kubow S. Oxysterol as a marker of atherogenic dyslipidemia in adolescence. J Clin Endocrinol Metab 2008;93:4282-4289 (Pubitemid 352789523)
23. Crosignani A, Del Puppo M, De Fabiani E, et al. Plasma oxysterols in normal and cholestatic children as indicators of the two pathways of bile acid synthesis. Clin Chim Acta 2008;395:84-88
24. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Collins CE, Garg ML. Oxidative stress in cystic fibrosis: dietary and metabolic factors. J Am Coll Nutr 2001;20(suppl):157-165
25. Milne GL, Sanchez SC, Musiek ES, Morrow JD. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc 2007;2:221-226 (Pubitemid 47040087)
26. Rise P, Camera M, Caruso D, Ghezzi S, Visioli F, Galli C. Synthesis of long-chain polyunsaturated fatty acids is inhibited in vivo in hypercholesterolemic rabbits and in vitro by oxysterols. Prostaglandins Leukot Essent Fatty Acids 2004;71:79-86. (Pubitemid 38881244)
27. Arca M, Natoli S, Micheletta F, et al. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy. Free Radic Biol Med 2007;42:698-705. (Pubitemid 46205153)
28. Strandvik B, Gronowitz E, Enlund F, Martinsson T, Wahlstrom J. Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. J Pediatr 2001;139:650-655 (Pubitemid 33097428)
29. Lloyd-Still JD, Johnson SB, Holman RT. Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation. Am J Clin Nutr 1981;34:1-7.
30. Strandvik B. Fatty acid metabolism in cystic fibrosis. N Engl J Med 2004;350:605-607 (Pubitemid 38160792)
31. Maqbool A, Schall JI, Garcia-Espana JF, Zemel BS, Strandvik B, Stallings VA. Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2008;47:635-644
32. Freedman SD, Katz MH, Parker EM, Laposata M, Urman MY, Alvarez JG. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice. Proc Natl Acad Sci USA 1999;96:13995-14000
33. Al-Turkmani MR, Freedman SD, Laposata M. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids 2007;77:309-318 (Pubitemid 350198866)
34. Strandvik B. Mediterranean diet and cystic fibrosis. Br J Nutr 2006;96:199-200.
35. McKarney C, Everard M, N'Diaye T. Omega-3 fatty acids (from fish oils) for cystic fibrosis. Cochrane Database Syst Rev 2007;4:CD002201. (Pubitemid 351805321)
36. Lee C, Barnett J, Reaven PD. Liposomes enriched in oleic acid are less susceptible to oxidation and have less proinflammatory activity when exposed to oxidizing conditions. J Lipid Res 1998;39:1239-1247 (Pubitemid 28270087)
37. Reaven P, Parthasarathy S, Grasse BJ, Miller E, Steinberg D, Witztum JL. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 1993;91:668-676 (Pubitemid 23064153)
38. Tsimikas S, Philis-Tsimikas A, Alexopoulos S, Sigari F, Lee C, Reaven PD. LDL isolated from Greek subjects on a typical diet or from American subjects on an oleate-supplemented diet induces less monocyte chemotaxis and adhesion when exposed to oxidative stress. Arterioscler Thromb Vasc Biol 1999;19:122-130 (Pubitemid 29031920)
39. Moreno JA, Lopez-Miranda J, Perez-Martinez P, et al. A mono-unsaturated fatty acid-rich diet reduces macrophage uptake of plasma oxidised low-density lipoprotein in healthy young men. Br J Nutr 2008;100:569-575